The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: a literature review.

Journal of managed care pharmacy : JMCP

Volumn 9, Issue 4, 2003, Pages 353-359

  Halpern, Michael T ^a   Higashi, Mitchell K ^a   Bakst, Alan W ^a   Schmier, Jordana K ^a  

^a EXPONENT INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

AGED; CANADA; CHRONIC BRONCHITIS; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MIDDLE AGED; QUALITY ADJUSTED LIFE YEAR; REVIEW; UNITED STATES;

AGED; ANTI-BACTERIAL AGENTS; BRONCHITIS, CHRONIC; CANADA; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 0642378194     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2003.9.4.353     Document Type: Review

References (16)